This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Edgar Schuck: Innovator in Pharmaceutical Composition
Introduction
Edgar Schuck is a notable inventor based in Parsippany, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on PDE9 inhibitors. His dedication to research and development has led to advancements that may benefit various therapeutic applications.
Latest Patents
Edgar Schuck holds a patent for a pharmaceutical composition comprising a PDE9 inhibitor. The specific compound detailed in his patent is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one or pharmaceutically acceptable salts thereof. This invention represents a significant step forward in the development of effective treatments.
Career Highlights
Throughout his career, Edgar has been associated with Eisai R&D Management Co., Ltd., where he has contributed to various research initiatives. His work has focused on creating innovative solutions that address unmet medical needs. With a patent portfolio that includes 1 patent, he has established himself as a key player in the pharmaceutical industry.
Collaborations
Edgar Schuck has collaborated with talented professionals such as Robert Lai and Ishani Savant Landry. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Edgar Schuck's contributions to the field of pharmaceuticals, particularly through his patent on PDE9 inhibitors, highlight his commitment to advancing medical science. His work continues to inspire future innovations in the industry.